Philip Bonomi to Receptor Protein-Tyrosine Kinases
This is a "connection" page, showing publications Philip Bonomi has written about Receptor Protein-Tyrosine Kinases.
Connection Strength
0.028
-
A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer. Clin Cancer Res. 2013 Jun 01; 19(11):3068-77.
Score: 0.028
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.